$0.6750
-0.03-4.67%
At close: -
$0.7000
0.023.70%
After Hours: Apr 4, 6:57 PM EDT
Comments
Loading...
Prelude Therapeutics Stock Guidance | NASDAQ:PRLD | Benzinga
Prelude Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prelude Therapeutics Inc (PRLD) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for Prelude Therapeutics (PRLD)?
There have been no specific sales or earnings guidance reported for Prelude Therapeutics in recent months.
Browse guidance and forecast on all stocks.